1. Home
  2. GLDD vs GERN Comparison

GLDD vs GERN Comparison

Compare GLDD & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$13.04

Market Cap

814.6M

Sector

Industrials

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.38

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
GERN
Founded
1890
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.6M
753.3M
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
GLDD
GERN
Price
$13.04
$1.38
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.00
AVG Volume (30 Days)
420.3K
7.0M
Earning Date
02-17-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
36.27
N/A
EPS
1.19
N/A
Revenue
$834,599,000.00
$183,403,000.00
Revenue This Year
$12.71
$147.42
Revenue Next Year
$4.77
$39.42
P/E Ratio
$11.02
N/A
Revenue Growth
12.53
522.13
52 Week Low
$7.51
$1.04
52 Week High
$14.02
$3.46

Technical Indicators

Market Signals
Indicator
GLDD
GERN
Relative Strength Index (RSI) 47.35 58.71
Support Level $13.28 $1.30
Resistance Level $13.80 $1.40
Average True Range (ATR) 0.31 0.06
MACD -0.08 -0.00
Stochastic Oscillator 7.32 61.54

Price Performance

Historical Comparison
GLDD
GERN

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: